Tang H, Kimmel SE, Hernandez I, Brooks MM, et al. Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes Obes Metab 2022;24:154-159.
PMID: 34472689